Date
- Wednesday, 17 September 2014, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
This is a joint Workshop with representatives from patients', consumers' and healthcare professionals' organisations. The workshop will provide an overview of how EMA communicates on the benefits and risks of medicines within the EU regulatory network. It will also discuss the role of communication in achieving effectiveness of risk minimisation measures and explore how such communication can support healthcare professionals and patients on their treatment decisions. Registration by invitation only.